The global COVID-19 vaccine supply is about to take another hit, but this time from Moderna. The mRNA drugmaker warned Friday that supply problems are forcing it to cut back deliveries to “a number of countries,” including the U.K. and Canada. Moderna, which has partnered with Switzerland’s Lonza to manufacture its vaccine known as mRNA-1273, pinned the reduction on deficits in… Read More »
It’s no secret that Clovis Oncology is up against some serious marketing muscle in the PARP inhibitor arena. And investors are doubting the company’s ability to hang in there. Shareholders headed for the exits Thursday after Clovis reported that Rubraca sales tallied just $ 33 million in the second quarter, coming in $ 2 million… Read More »
Border Patrol agents have spent nearly 20,000 hours since October driving asylum seekers to and from hospitals for medical evaluations, according to newly released Department of Homeland Security data. Since Oct. 1, 2018, the Border Patrol, which works in rural areas between border crossings, has “seen an increase in the numbers of apprehended individuals requiring… Read More »